| LINE ITEM (USD / %) | FY 2025
FILED 2025-06-30 | FY 2024
FILED 2024-06-30 | FY 2023
FILED 2023-06-30 |
|---|---|---|---|
| Revenue (Total Sales) | $16.30B | $13.98B | $14.91B |
| YoY Revenue Growth % | +16.6% | -6.3% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $2.67B | $1.77B | $1.46B |
| Operating Margin % | 16.4% | 12.7% | 9.8% |
| Net Income (GAAP) | $2.26B | $1.50B | $1.24B |
| EBITDA (Normalized) | $2.94B | $2.05B | $2.00B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $3.32B | $1.84B | $1.80B |
| Capital Expenditures (CapEx) | $331.0M | $345.0M | $671.1M |
| Free Cash Flow (FCF) | $2.99B | $1.50B | $1.13B |
| FCF Margin % | 18.4% | 10.7% | 7.6% |
| Return on Invested Capital (ROIC %) | 13.9% | 9.0% | 10.7% |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $6.60B | $6.60B | $4.19B |
| Total Stockholders' Equity | $10.93B | $11.49B | $8.59B |